Results underscore clinical utility of novel circulating tumor DNA assay to detect disease recurrence Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, ...

The Consumer Electronics Association said its Technology and Standards committees are revising and developing standards for home and car audio testing methods. The Mobile Electronics Committee plans ...

Clinical Genomics has launched a blood-based test for monitoring colorectal cancer recurrence called Colvera, the company announced. “Current professional guidelines recommend inclusion of the ...

Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...

NEW YORK (Reuters Health) - The results of new research indicate that many older patients who survive colorectal cancer do not attend the guideline-recommended follow-up office visits or undergo ...

LONDON, June 29, 2017 /PRNewswire/ -- The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover ...

PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced the launch of a new, patent-pending, customized test to accurately measure ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The Consumer Electronics Association has released DTV Closed Captioning (DTVCC) test materials on ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The Consumer Electronics Association (CEA) has released Digital Television Closed Captioning ...

Arlington, Va. — The Consumer Electronics Association’s (CEA) antennas committee today announced revisions to its antenna testing standard to include the testing of self-adjusting “smart” antennas.

Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States. Background: Relapse after ...